BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7482685)

  • 1. Inhibition of trazodone metabolism by thioridazine in humans.
    Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Ishida M; Mihara K; Kondo T; Sugawara K; Fukushima Y
    Ther Drug Monit; 1995 Aug; 17(4):333-5. PubMed ID: 7482685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increases in plasma concentration of m-chlorophenylpiperazine, but not trazodone, with low-dose haloperidol.
    Mihara K; Otani K; Ishida M; Yasui N; Suzuki A; Ohkubo T; Osanai T; Kaneko S; Sugawara K
    Ther Drug Monit; 1997 Feb; 19(1):43-5. PubMed ID: 9029745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between steady-state plasma concentrations of mianserin and trazodone in depressed patients.
    Otani K; Tybring G; Mihara K; Yasui N; Kaneko S; Ohkubo T; Nagasaki T; Sugawara K
    Eur J Clin Pharmacol; 1998 Jan; 53(5):347-9. PubMed ID: 9516035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carbamazepine coadministration on plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine.
    Otani K; Ishida M; Kaneko S; Mihara K; Ohkubo T; Osanai T; Sugawara K
    Ther Drug Monit; 1996 Apr; 18(2):164-7. PubMed ID: 8721280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of genetic polymorphism of CYP1A2 inducibility on the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine in depressed Japanese patients.
    Mihara K; Kondo T; Suzuki A; Yasui-Furukori N; Ono S; Otani K; Kaneko S
    Pharmacol Toxicol; 2001 May; 88(5):267-70. PubMed ID: 11393588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the CYP2D6 genotype and the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine.
    Mihara K; Otani K; Suzuki A; Yasui N; Nakano H; Meng X; Ohkubo T; Nagasaki T; Kaneko S; Tsuchida S; Sugawara K; Gonzalez FJ
    Psychopharmacology (Berl); 1997 Sep; 133(1):95-8. PubMed ID: 9335086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thioridazine, an inhibitor of CYP2D6, on the steady-state plasma concentrations of the enantiomers of mianserin and its active metabolite, desmethylmianserin, in depressed Japanese patients.
    Yasui N; Tybring G; Otani K; Mihara K; Suzuki A; Svensson JO; Kaneko S
    Pharmacogenetics; 1997 Oct; 7(5):369-74. PubMed ID: 9352572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients.
    Mihara K; Yasui-Furukori N; Kondo T; Ishida M; Ono S; Ohkubo T; Osanai T; Sugawara K; Otani K; Kaneko S
    Ther Drug Monit; 2002 Aug; 24(4):563-6. PubMed ID: 12142643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of trazodone and m-chlorophenylpiperazine at steady state can be predicted from those after an initial dose of trazodone.
    Otani K; Mihara K; Yasui N; Ishida M; Kondo T; Tokinaga N; Ohkubo T; Osanai T; Sugawara K; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jan; 21(1):239-44. PubMed ID: 9075270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources.
    Rotzinger S; Fang J; Baker GB
    Drug Metab Dispos; 1998 Jun; 26(6):572-5. PubMed ID: 9616194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of various factors on steady state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine.
    Ishida M; Otani K; Kaneko S; Ohkubo T; Osanai T; Yasui N; Mihara K; Higuchi H; Sugawara K
    Int Clin Psychopharmacol; 1995 Sep; 10(3):143-6. PubMed ID: 8675966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of novel reactive metabolites of trazodone: evidence for CYP2D6-mediated bioactivation of m-chlorophenylpiperazine.
    Wen B; Ma L; Rodrigues AD; Zhu M
    Drug Metab Dispos; 2008 May; 36(5):841-50. PubMed ID: 18238857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose proportionality of once-daily trazodone extended-release caplets under fasting conditions.
    Karhu D; Groenewoud G; Potgieter MA; Mould DR
    J Clin Pharmacol; 2010 Dec; 50(12):1438-49. PubMed ID: 20173086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trazodone generates m-CPP: in 2008 risks from m-CPP might outweigh benefits of trazodone.
    Kast RE
    World J Biol Psychiatry; 2009; 10(4 Pt 2):682-5. PubMed ID: 19384678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.
    Maes M; Westenberg H; Vandoolaeghe E; Demedts P; Wauters A; Neels H; Meltzer HY
    J Clin Psychopharmacol; 1997 Oct; 17(5):358-64. PubMed ID: 9315986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma concentrations of bromperidol and its reduced metabolite with levomepromazine, but not with thioridazine.
    Suzuki A; Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Kaneko S; Inoue Y; Shibata M; Ikeda K
    Ther Drug Monit; 1997 Jun; 19(3):261-4. PubMed ID: 9200764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextromethorphan and mephenytoin phenotyping of patients treated with thioridazine or amitriptyline.
    Baumann P; Meyer JW; Amey M; Baettig D; Bryois C; Jonzier-Perey M; Koeb L; Monney C; Woggon B
    Ther Drug Monit; 1992 Feb; 14(1):1-8. PubMed ID: 1546384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic determination of trazodone and 1-m-chlorophenylpiperazine with ultraviolet and electrochemical detector.
    Ohkubo T; Osanai T; Sugawara K; Ishida M; Otani K; Mihara K; Yasui N
    J Pharm Pharmacol; 1995 Apr; 47(4):340-4. PubMed ID: 7791034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trazodone treatment increases plasma prolactin concentrations in depressed patients.
    Otani K; Yasui N; Kaneko S; Ishida M; Ohkubo T; Osanai T; Sugawara K; Fukushima Y
    Int Clin Psychopharmacol; 1995 Jun; 10(2):115-7. PubMed ID: 7673654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of trazodone and its metabolite, 1-m-chlorophenyl-piperazine, in human plasma and red blood cell samples by HPLC.
    Vatassery GT; Holden LA; Hazel DK; Dysken MW
    Clin Biochem; 1997 Mar; 30(2):149-53. PubMed ID: 9127697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.